Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Cystic Fibrosis: Microbiology and Host Response.

Zemanick ET, Hoffman LR.

Pediatr Clin North Am. 2016 Aug;63(4):617-36. doi: 10.1016/j.pcl.2016.04.003. Review.

PMID:
27469179
2.

Toxin-Antitoxin Systems in Clinical Pathogens.

Fernández-García L, Blasco L, Lopez M, Bou G, García-Contreras R, Wood T, Tomas M.

Toxins (Basel). 2016 Jul 20;8(7). pii: E227. doi: 10.3390/toxins8070227. Review.

3.

Comparative genome-wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci required for pathogenesis.

Deng P, Wang X, Baird SM, Showmaker KC, Smith L, Peterson DG, Lu S.

Microbiologyopen. 2016 Jun;5(3):353-69. doi: 10.1002/mbo3.333. Epub 2016 Jan 14.

4.

period-Regulated Feeding Behavior and TOR Signaling Modulate Survival of Infection.

Allen VW, O'Connor RM, Ulgherait M, Zhou CG, Stone EF, Hill VM, Murphy KR, Canman JC, Ja WW, Shirasu-Hiza MM.

Curr Biol. 2016 Jan 25;26(2):184-94. doi: 10.1016/j.cub.2015.11.051. Epub 2015 Dec 31.

PMID:
26748856
5.

Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells.

David J, Bell RE, Clark GC.

Front Cell Infect Microbiol. 2015 Nov 18;5:80. doi: 10.3389/fcimb.2015.00080. eCollection 2015. Review.

6.

Vaccine strategies against cystic fibrosis pathogens.

Le Moigne V, Gaillard JL, Herrmann JL.

Hum Vaccin Immunother. 2016 Mar 3;12(3):751-6. doi: 10.1080/21645515.2015.1102810.

PMID:
26618824
7.

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis.

Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, Høiby N, Katzenstein TL, Smyth RL, Diggle PJ, Pressler T.

J Cyst Fibros. 2016 May;15(3):380-5. doi: 10.1016/j.jcf.2015.09.007. Epub 2015 Oct 9.

8.

Genome-wide transcription start site profiling in biofilm-grown Burkholderia cenocepacia J2315.

Sass AM, Van Acker H, Förstner KU, Van Nieuwerburgh F, Deforce D, Vogel J, Coenye T.

BMC Genomics. 2015 Oct 13;16:775. doi: 10.1186/s12864-015-1993-3.

9.

Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.

Hwang J, Kim HS.

Antimicrob Agents Chemother. 2015 Dec;59(12):7602-10. doi: 10.1128/AAC.01068-15. Epub 2015 Sep 28.

10.

Genome-wide RNA sequencing analysis of quorum sensing-controlled regulons in the plant-associated Burkholderia glumae PG1 strain.

Gao R, Krysciak D, Petersen K, Utpatel C, Knapp A, Schmeisser C, Daniel R, Voget S, Jaeger KE, Streit WR.

Appl Environ Microbiol. 2015 Dec;81(23):7993-8007. doi: 10.1128/AEM.01043-15. Epub 2015 Sep 11.

11.

"You can't always get what you want…" the Mycobacterium abscessus issue. Name versus function.

Zelazny AM, Olivier KN.

Ann Am Thorac Soc. 2015 Mar;12(3):300-2. doi: 10.1513/AnnalsATS.201502-087ED. No abstract available.

12.

Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens.

Srinivasan R, Karaoz U, Volegova M, MacKichan J, Kato-Maeda M, Miller S, Nadarajan R, Brodie EL, Lynch SV.

PLoS One. 2015 Feb 6;10(2):e0117617. doi: 10.1371/journal.pone.0117617. eCollection 2015.

13.

Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine.

De Groot AS, Ardito M, Moise L, Gustafson EA, Spero D, Tejada G, Martin W.

Immunome Res. 2011 May;7(2). pii: e7.

14.

Atypical presentation of chronic granulomatous disease with Burkholderia cepacia.

Vining M, Sharma N, Guill M.

BMJ Case Rep. 2014 Aug 6;2014. pii: bcr2013201524. doi: 10.1136/bcr-2013-201524.

15.

RsaM: a transcriptional regulator of Burkholderia spp. with novel fold.

Michalska K, Chhor G, Clancy S, Jedrzejczak R, Babnigg G, Winans SC, Joachimiak A.

FEBS J. 2014 Sep;281(18):4293-306. doi: 10.1111/febs.12868. Epub 2014 Jul 4.

16.

Impact of multidrug-resistant organisms on patients considered for lung transplantation.

Shoham S, Shah PD.

Infect Dis Clin North Am. 2013 Jun;27(2):343-58. doi: 10.1016/j.idc.2013.02.006. Epub 2013 Apr 17. Review.

17.

Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species.

Van Acker H, Sass A, Bazzini S, De Roy K, Udine C, Messiaen T, Riccardi G, Boon N, Nelis HJ, Mahenthiralingam E, Coenye T.

PLoS One. 2013;8(3):e58943. doi: 10.1371/journal.pone.0058943. Epub 2013 Mar 13.

18.

Host evasion by Burkholderia cenocepacia.

Ganesan S, Sajjan US.

Front Cell Infect Microbiol. 2012 Jan 11;1:25. doi: 10.3389/fcimb.2011.00025. eCollection 2011. Review.

19.

Burkholderia cenocepacia type VI secretion system mediates escape of type II secreted proteins into the cytoplasm of infected macrophages.

Rosales-Reyes R, Aubert DF, Tolman JS, Amer AO, Valvano MA.

PLoS One. 2012;7(7):e41726. doi: 10.1371/journal.pone.0041726. Epub 2012 Jul 25.

20.

Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study.

Collaco JM, McGready J, Green DM, Naughton KM, Watson CP, Shields T, Bell SC, Wainwright CE; ACFBAL Study Group, Cutting GR.

PLoS One. 2011;6(11):e27784. doi: 10.1371/journal.pone.0027784. Epub 2011 Nov 18.

Items per page

Supplemental Content

Write to the Help Desk